Analyst Ratings for Maravai LifeScience Holdings Inc. (MRVI)
MRVI Rating Summary
MRVI Price Target Summary
- Highest: $5.00 (RBC Capital)
- Lowest: $3.00 (Baird)
- Average: $4.30
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$4.30 (+21.1%)
* Over Last 12-Mos
Rating Score: 4.4 / 10
Percentile Rank: 45%
Rating Score: 4.4 / 10
Percentile Rank: 45%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/26/2025 | Baird » Updated 2/26/2026 |
Catherine Schulte | Downgrade | Neutral (Outperform) |
3.00 (2.00) |
4.01 (3.55) |
-11.47% | Details |
| 12/19/2024 | Guggenheim | Subbu Nambi | New Coverage | Neutral (N/A) |
N/A (N/A) |
5.58 (3.55) |
-36.38% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
